Program in HIV Medicine
The Program in HIV Medicine focuses primarily on HIV pathogenesis and will build on and formalize the current network of investigators from the Medical School, the College of Veterinary Medicine, College of Pharmacy, and the School of Public Health.
- Support and sustain the existing strengths of the University of Minnesota in HIV research, which has focused predominately on HIV pathogenesis with more recent research investigating cures for HIV
- Support the current network of HIV researchers in the Medical School, the College of Veterinary Medicine, College of Pharmacy, and the School of Public Health
Recent Development: Studying Potential Antiretroviral Treatments for HIV
In a recent publication in Nature Medicine, University of Minnesota researchers report the results of a phase one trial of the IL-15 superagonist N-803 in people living with HIV.
The results of their study indicate that the medication was safe for individuals living with antiretroviral therapy-suppressed HIV, and that further study was warranted to determine the impact of N-803 on HIV reservoirs.
Image source: https://www.nature.com/articles/s41591-021-01651-9